Home5Position Paper5Medication related osteonecrosis (MRONJ) in the management of CTIBL inbreast and prostate cancer patients. Joint report by SIPMO AND SIOMMMS
20/01/2025
Medication related osteonecrosis (MRONJ) in the management of CTIBL inbreast and prostate cancer patients. Joint report by SIPMO AND SIOMMMS
Commento all’articolo: SPI1 activates mitochondrial unfolded response signaling to inhibit chondrocyte senescence and relieves osteoarthritis. Zu X, Chen S, Li Z, Hao L, Fu W, Zhang H, Yin Z, Wang Y, Wang J. Bone Res. 2025 Apr 14;13(1):47. doi:...
Commento all’articolo: Porcupine inhibition is a promising pharmacological treatment for severe sclerosteosis pathologies. Dreyer TJ, Keen JAC, Wells LM, Hopkinson M, Orriss IR, Holdsworth G, Pitsillides AA, Roberts SJ. Bone Res. 2025 Apr 7;13(1):44. doi:...